<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Granulomatous gastritis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Granulomatous gastritis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Granulomatous gastritis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark Feldman, MD, MACP, AGAF, FACG</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Pamela J Jensen, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 04, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>A granuloma is an organized aggregation of combined histiocytic, lymphocytic, and plasmacytic infiltrates (granulomatous inflammation). When this organized collection of cells is identified in the stomach, it is referred to as granulomatous gastritis.</p><p>This topic review will discuss the epidemiology, etiology, histopathology, and diagnosis of granulomatous gastritis. The classification of gastritis and causes of acute and chronic gastritis are presented separately. (See  <a class="medical medical_review" href="/z/d/html/29.html" rel="external">"Gastritis: Etiology and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/31.html" rel="external">"Acute and chronic gastritis due to Helicobacter pylori"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Granulomatous gastritis is rare, with an incidence in gastric biopsies of approximately 0.35 percent [<a href="#rid1">1-5</a>]. In one large series, only 56 cases were diagnosed after review of 15,947 biopsies/resections [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H3"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Granulomatous gastritis is a type of chronic gastritis and can be subclassified based on the etiology into infectious, noninfectious, and idiopathic granulomatous gastritis [<a href="#rid5">5</a>].</p><p>A specific cause can be identified in most patients found to have granulomatous gastritis [<a href="#rid2">2,6</a>]. The most likely causes vary by geography and ethnicity. Most cases of granulomatous gastritis in resource-abundant countries are noninfectious with the most common causes being Crohn disease and sarcoidosis [<a href="#rid2">2,3,7</a>]. In contrast, in resource-limited countries, infections, particularly tuberculosis,<em> </em>are the most common cause of granulomatous gastritis [<a href="#rid8">8</a>].</p><p>In a Belgian cohort in which biopsies from 71 patients with granulomatous gastritis were reviewed, the most common causes of granulomatous gastritis were [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Crohn disease (55 percent) or possible Crohn disease (2 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis (21 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Distal esophageal adenocarcinoma with chronic active gastritis (5 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Mucosa-associated lymphoid tissue (MALT) lymphoma (5 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Peptic ulcer complications (5 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Hypertrophic gastropathy and chronic active gastritis (2 percent)</p><p></p><p>In a study from Korea, 18 of 22,643 patients (0.08 percent) biopsied were diagnosed with granulomatous gastritis over a six-year period (1997 to 2002) [<a href="#rid4">4</a>]. Of those, 14 had chronic <em>Helicobacter pylori</em> gastritis, two had gastric adenocarcinoma, one had chronic gastritis without <em>H. pylori</em>, and one had Crohn disease.</p><p>A retrospective review of 23 children and 23 adults with granulomatous gastritis in a southern United States medical center demonstrated age- and race-related differences in the etiologies of granulomatous gastritis [<a href="#rid9">9</a>]. In the children (average age 12 years), the most common diagnosis was Crohn disease. In the adults (average age 49 years), who were most often African American, the leading diagnoses were sarcoidosis and idiopathic granulomatous gastritis. </p><p class="headingAnchor" id="H124999776"><span class="h2">Noninfectious causes</span></p><p class="headingAnchor" id="H4"><span class="h3">Crohn disease</span><span class="headingEndMark"> — </span>Although granulomatous gastritis is rare in Crohn disease, this is the most common etiology of granulomatous gastritis in resource-abundant countries. While clinically apparent gastritis is seen in only 2 to 7 percent of patients with Crohn disease, microscopic involvement may be detected in up to 75 percent of patients with Crohn disease and endoscopically normal mucosa [<a href="#rid9">9-12</a>].</p><p>In a retrospective study of 269 cases of granulomatous gastritis of which 185 (68.8 percent) were due to Crohn disease, patients with Crohn disease were more likely to be younger and male, relative to other etiologies of granulomatous gastritis [<a href="#rid7">7</a>]. The granulomas tended to be single or located in the gastric antrum. Upper gastrointestinal symptoms were often present.</p><p>Individuals with Crohn disease of the stomach may have focally enhanced gastritis (FEG), a focal inflammatory lesion composed of lymphocytes, histiocytes, and admixed granulocytes (which involve either one or a few adjacent foveolae) in a background of normal gastric mucosa. FEG is more frequent in the gastric antrum than in the gastric body [<a href="#rid13">13</a>] and is more commonly seen with Crohn disease when compared with other causes of granulomatous gastritis [<a href="#rid7">7</a>]. Lymphocytic gastritis may also be present [<a href="#rid6">6</a>]. Approximately 10 to 33 percent of these patients will have <em>H. pylori</em> infection with chronic active gastritis [<a href="#rid6">6</a>].</p><p>Granulomatous gastritis is present in approximately one-third of individuals with Crohn disease and a normal microscopic exam. The rate may be higher with increased tissue sampling [<a href="#rid14">14</a>]. These granulomas are mucosal but are sharply separated from the foveolar epithelium and often poorly formed (<a class="graphic graphic_picture graphicRef61180" href="/z/d/graphic/61180.html" rel="external">picture 1</a>) [<a href="#rid4">4</a>].</p><p>Granulomatous gastritis may be present in patients with known Crohn colitis or ileitis or may be the first manifestation of Crohn disease, particularly in children. In patients with the histopathologic findings of FEG or granulomatous gastritis, or with symptoms suggestive of inflammatory bowel disease, a search for intestinal Crohn disease should be undertaken [<a href="#rid2">2,3</a>]. (See  <a class="medical medical_review" href="/z/d/html/4070.html" rel="external">"Clinical manifestations, diagnosis, and prognosis of Crohn disease in adults"</a>.)</p><p class="headingAnchor" id="H5"><span class="h3">Sarcoidosis</span><span class="headingEndMark"> — </span>Within the gastrointestinal (GI) tract, the stomach is the most commonly affected site in sarcoidosis [<a href="#rid15">15</a>]. Gastric granulomas found in patients with systemic sarcoidosis are usually asymptomatic. Subclinical GI tract involvement has been identified in 5 to 10 percent of patients with systemic sarcoidosis, while symptomatic granulomatous gastritis has been reported in less than 1 percent [<a href="#rid16">16</a>]. Symptomatic forms are dependent on the site of involvement in the stomach and range from ulcerative lesions to lesions that are polypoid with gastric outlet obstruction. Infiltrative and hyperplastic patterns of involvement may mimic Ménétrier's disease or linitis plastica carcinoma [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/z/d/html/4317.html" rel="external">"Gastrointestinal, hepatic, pancreatic, and peritoneal sarcoidosis"</a>.)</p><p class="headingAnchor" id="H8"><span class="h3">Other causes</span><span class="headingEndMark"> — </span>Rare noninfectious causes of granulomatous gastritis include tumors (upper GI tract adenocarcinoma and MALT lymphoma), vasculitides (eg, granulomatosis with polyangiitis [GPA] and eosinophilic granulomatosis with polyangiitis [EGPA]), drugs (eg, cocaine, carbimazole, and interferon), xanthogranulomatous gastritis, foreign body reactions to stomach contents within an ulcer repair zone or to surgical material (eg, suture), crystalline drugs (eg, antacids containing magnesium, aluminium, and silicon), reaction to endogenous materials (mucin, lipid, or crystalline material), Langerhans cell histiocytosis (which is more common in childhood), and chronic granulomatous disease (which is also more common in childhood and adolescence) [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/z/d/html/3117.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/8385.html" rel="external">"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis"</a> and  <a class="medical medical_review" href="/z/d/html/3925.html" rel="external">"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H124999878"><span class="h2">Infectious causes</span><span class="headingEndMark"> — </span>An association with granulomatous gastritis and <em>H. pylori</em> has been described [<a href="#rid3">3,4,19,20</a>], although evidence does not support <em>H. pylori</em> as an etiologic agent in most cases of granulomatous gastritis [<a href="#rid18">18,21</a>]. In a review of 18,000 gastric biopsies, <em>H. pylori</em> was only identified in 6 of 16 granulomatous biopsies [<a href="#rid22">22</a>]. In a subsequent series of 71 patients, 92 percent of biopsies contained <em>H. pylori</em>; however, many diverse etiologies for the associated granulomatous gastritis were also found [<a href="#rid2">2</a>].</p><p>Isolated granulomatous gastritis associated with <em>H. pylori</em> has reportedly shown improvement after eradication therapy for the <em>H. pylori</em>, although persistence of granulomas after 12 to 17 months was noted [<a href="#rid23">23</a>]. </p><p>While <em>H. pylori</em> infection with related chronic active gastritis may be responsible for rare cases of granulomatous gastritis, a search for other causes of granulomata must be undertaken when <em>H. pylori</em> is present [<a href="#rid1">1,22</a>]. It is currently not known whether granulomatous gastritis responds to <em>H. pylori</em> eradication [<a href="#rid24">24</a>].</p><p>Other infections that can cause granulomatous gastritis include tuberculosis, syphilis, Whipple disease, a variety of fungal infections including cryptococcosis, as well as anisakidosis, taeniasis, and infestations with other parasitic worms and schistosomes. (See  <a class="medical medical_review" href="/z/d/html/8024.html" rel="external">"Clinical manifestations, diagnosis, and treatment of miliary tuberculosis"</a> and  <a class="medical medical_review" href="/z/d/html/7597.html" rel="external">"Syphilis: Treatment and monitoring"</a> and  <a class="medical medical_review" href="/z/d/html/2702.html" rel="external">"Whipple's disease"</a> and  <a class="medical medical_review" href="/z/d/html/5685.html" rel="external">"Tapeworm infections"</a> and  <a class="medical medical_review" href="/z/d/html/5717.html" rel="external">"Schistosomiasis: Epidemiology and clinical manifestations"</a> and  <a class="medical medical_review" href="/z/d/html/5682.html" rel="external">"Schistosomiasis: Diagnosis"</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Idiopathic granulomatous gastritis</span><span class="headingEndMark"> — </span>In up to 25 percent of cases a cause of granulomatous gastritis cannot be identified [<a href="#rid2">2</a>]. These patients are considered to have idiopathic or isolated granulomatous gastritis [<a href="#rid18">18,25</a>]. The clinical importance of idiopathic granulomatous gastritis and its existence as a distinctive condition are uncertain [<a href="#rid25">25,26</a>]. It is possible that "idiopathic" granulomatous gastritis represents a nonspecific inflammatory reaction to an as yet unknown or undiscovered agent [<a href="#rid2">2,4</a>]. Some of these patients may also eventually be diagnosed with a known cause (eg, sarcoidosis or Crohn disease). Therefore the use of the descriptive terminology granulomatous gastritis of uncertain etiology rather than the term idiopathic or isolated granulomatous gastritis as a specific diagnosis has been suggested [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H10"><span class="h1">HISTOPATHOLOGIC FEATURES</span><span class="headingEndMark"> — </span>Granulomatous gastritis encompasses a broad spectrum of histopathologic features ranging from vague, ill-defined collections of mucosal/submucosal macrophages to fully formed granulomas with giant cells and palisading histiocytes. </p><p class="headingAnchor" id="H11"><span class="h2">Granuloma type</span><span class="headingEndMark"> — </span>Granulomas may be non-caseating, caseating, or necrotizing. Caseation is usually associated with an infectious etiology that may be bacterial or fungal (eg, <em>Mycobacterium tuberculosis</em>, atypical mycobacteria, histoplasmosis). Well-defined, non-caseating epithelioid granulomas with a circumscribed solid appearance are commonly seen in sarcoidosis. Non-caseating granulomas are also seen in Crohn disease and occasionally in association with <em>H. pylori</em>. Necrotizing granulomas, especially if associated with vasculitis, suggest eosinophilic granulomatosis with polyangiitis (EGPA) or granulomatosis with polyangiitis (GPA).</p><p>Whereas the morphologic features of the granulomas may yield a clue to the etiology, in many cases the granulomas are morphologically nonspecific. Special stains are needed to rule out infectious etiologies (acid-fast stains and silver impregnation stains, or specific immunohistochemical stains for designated microorganisms).</p><p class="headingAnchor" id="H12"><span class="h2">Granuloma environment</span><span class="headingEndMark"> — </span>The tissue surrounding the granulomas may also contain a clue to the etiology of the granulomatous gastritis. In Crohn disease, the gastric mucosa may demonstrate focally enhanced gastritis, and in granulomatous disease associated with <em>H. pylori</em>, a chronic active gastritis or chronic atrophic gastritis may be present [<a href="#rid21">21</a>]. An infiltrate rich in eosinophils is suggestive of a parasitic infection, drug-induced mucosal injury, or EGPA. The presence of isolated compact granulomas sometimes surrounded by lymphocytes in otherwise normal-appearing mucosa is suggestive of sarcoidosis [<a href="#rid21">21</a>]. Gastric involvement in syphilis is characterized by a dense lymphoplasmacytic and granulomatous infiltrate often in a perivascular distribution [<a href="#rid27">27-29</a>]. </p><p class="headingAnchor" id="H13"><span class="h2">Other features</span><span class="headingEndMark"> — </span>Diseases with granulomatous infiltrates, instead of having well-formed granulomas, may have specific morphologic features, such as Langerhans cell histiocytosis, in which the macrophages are reniform and are CD1a-positive. The presence of necrotizing granulomatous vasculitis is consistent with GPA. EGPA (Churg-Strauss syndrome) is characterized by extravascular granulomatous inflammation with eosinophils comprising the predominant cell type in the inflammatory infiltrate. Xanthogranulomatous gastritis (XGG), a specific subtype of granulomatous gastritis, can present as a mass lesion, mimicking a gastrointestinal stromal tumor or other gastric tumor when it involves the muscularis propria of the gastric wall [<a href="#rid30">30-32</a>]. A case of XGG associated with gastric actinomycosis has been described [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H7873253"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Patients may be asymptomatic or present with epigastric abdominal pain. Nausea, vomiting, and weight loss may result from gastric outlet obstruction. Patients with concomitant intestinal involvement (eg, from Crohn disease) may have diarrhea. Upper gastrointestinal bleeding, although rare, has been reported in patients with sarcoidosis and may occasionally be massive and fatal [<a href="#rid34">34,35</a>]. Other clinical features vary based on the underlying etiology. (See  <a class="medical medical_review" href="/z/d/html/4317.html" rel="external">"Gastrointestinal, hepatic, pancreatic, and peritoneal sarcoidosis"</a> and  <a class="medical medical_review" href="/z/d/html/5586.html" rel="external">"Sarcoid myopathy"</a> and  <a class="medical medical_review" href="/z/d/html/4070.html" rel="external">"Clinical manifestations, diagnosis, and prognosis of Crohn disease in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2702.html" rel="external">"Whipple's disease"</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of granulomatous gastritis is based on the histopathologic evaluation of gastric tissue. Granulomatous gastritis is considered to be present when there is a nodular, fairly circumscribed collection of epithelioid histiocytes, often mixed with a lymphocytic and plasmacytic infiltrate in the stomach. (See <a class="local">'Histopathologic features'</a> above.)</p><p>An approach to the diagnosis of granulomatous gastritis is outlined in the algorithm (<a class="graphic graphic_algorithm graphicRef90131" href="/z/d/graphic/90131.html" rel="external">algorithm 1</a>) [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H209914483"><span class="h2">Evaluation to determine the underlying etiology</span><span class="headingEndMark"> — </span>The following approach may be used to determine the underlying cause of granulomatous gastritis:</p><p class="bulletIndent1"><span class="glyph">●</span>A clinical history should include a history of residence in or travel to areas endemic for certain infectious diseases (eg, <em>Mycobacterium tuberculosis</em>, atypical mycobacteria, histoplasmosis, <em>H. pylori, </em>schistosomiasis, teniasis), high-risk behaviors (eg, cocaine, syphilis), medications (eg, antacids), pulmonary or systemic symptoms (eg, sarcoidosis, eosinophilic granulomatosis with polyangiitis, Whipple's disease, mucosa-associated lymphoid tissue lymphoma), and/or evidence of lower gastrointestinal symptoms (eg, Crohn disease, Whipple's disease).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A careful endoscopic inspection of the stomach with biopsies to map the extent of the disease process should be undertaken. The endoscopic appearance of granulomatous gastritis may reveal erythema, erosions, ulcers, rugal hypertrophy or luminal obstruction simulating malignancy or be completely normal [<a href="#rid22">22,36</a>]. Note should be made of the presence of suture material. Multiple biopsies of the gastric mucosa should be obtained to increase diagnostic yield, as granulomas may be present in endoscopically normal mucosa. If endoscopic inspection is unrevealing, additional studies may be indicated (eg, endoscopic ultrasound, computed tomography scan) if malignancy is suspected.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Histopathologic examination should include hematoxylin and eosin stains to evaluate the number of granulomas, location of the granulomas, and the nature of the inflammatory background of surrounding gastric mucosa. Certain histopathologic features may be suggestive of the underlying etiology. For example, the presence of caseating necrosis may be due to mycobacterial or fungal infections (<em>Mycobacterium tuberculosis</em>, atypical mycobacteria, histoplasmosis). The presence of well-defined epithelioid granulomas surrounded by normal-appearing mucosa is suggestive of sarcoidosis. Non-caseating granulomas are seen with Crohn disease and occasionally in association with <em>H. pylori</em>. In Crohn disease, the gastric mucosa may demonstrate focally enhanced gastritis. Necrotizing granulomas, especially if associated with vasculitis, suggest granulomatosis with polyangiitis. Special stains should be performed for specific bacteria/fungi (acid-fast stains and silver impregnation stains, or specific immunohistochemical stains for designated microorganisms). Polarization microscopy should be performed to look for birefringent material (foreign body). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Laboratory testing, colonoscopy, and imaging studies should be based on clinical suspicion (eg, chest radiography for tuberculosis and sarcoidosis, angiotensin-converting enzyme level for sarcoidosis, serum antineutrophil cytoplasmic antibodies for GPA, and serologic tests for syphilis). (See  <a class="medical medical_review" href="/z/d/html/8024.html" rel="external">"Clinical manifestations, diagnosis, and treatment of miliary tuberculosis"</a> and  <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a> and  <a class="medical medical_review" href="/z/d/html/3117.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/7588.html" rel="external">"Syphilis: Screening and diagnostic testing"</a>.)</p><p></p><p class="headingAnchor" id="H15"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Granulomatous gastritis is a type of chronic gastritis that may be infectious, noninfectious, or idiopathic in etiology. Granulomatous gastritis is rare, with an incidence in gastric biopsies of approximately 0.35 percent. Granulomatous gastritis encompasses a broad spectrum of histopathologic features ranging from vague, ill-defined collections of mucosal/submucosal macrophages to fully formed granulomas with giant cells and palisades of histiocytes. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – In resource-abundant countries, the most common causes of granulomatous gastritis are Crohn disease and sarcoidosis, while in resource-limited countries, infectious causes are more common. The cause of granulomatous gastritis cannot be identified in up to 25 percent of patients. These individuals are considered to have "granulomatous gastritis of uncertain etiology." Some of these patients will eventually present with an identifiable etiology for the granulomatous gastritis. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Patients may be asymptomatic or present with epigastric abdominal pain. Nausea, vomiting, and weight loss may result from gastric outlet obstruction. Patients with concomitant intestinal involvement (eg, from Crohn disease) may have diarrhea. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>–<strong> </strong>The diagnosis of granulomatous gastritis is based on the histopathologic evaluation of gastric tissue. Granulomatous gastritis is considered to be present when there is a nodular, fairly circumscribed collection of epithelioid histiocytes, often mixed with a lymphocytic and plasmacytic infiltrate in the stomach. (See <a class="local">'Histopathologic features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Determining the etiology </strong>–<strong> </strong>Evaluation of patients to determine the underlying etiology of granulomatous gastritis requires a detailed clinical history and endoscopic evaluation including biopsies for histopathologic examination that includes hematoxylin and eosin stains (<a class="graphic graphic_algorithm graphicRef90131" href="/z/d/graphic/90131.html" rel="external">algorithm 1</a>). Special stains should be performed for designated organisms/fungi (acid-fast stains and silver impregnation stains, or specific immunohistochemical stains) and polarization. (See <a class="local">'Histopathologic features'</a> above.)</p><p></p><p class="bulletIndent1">Additional laboratory testing, colonoscopy, and imaging studies should be performed to establish the etiology of granulomatous gastritis, based on the clinical setting. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="headingAnchor" id="H89442213"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Beverly Dickson, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Shapiro JL, Goldblum JR, Petras RE. A clinicopathologic study of 42 patients with granulomatous gastritis. Is there really an "idiopathic" granulomatous gastritis? Am J Surg Pathol 1996; 20:462.</a></li><li><a class="nounderline abstract_t">Ectors NL, Dixon MF, Geboes KJ, et al. Granulomatous gastritis: a morphological and diagnostic approach. Histopathology 1993; 23:55.</a></li><li><a class="nounderline abstract_t">Maeng L, Lee A, Choi K, et al. Granulomatous gastritis: a clinicopathologic analysis of 18 biopsy cases. Am J Surg Pathol 2004; 28:941.</a></li><li><a class="nounderline abstract_t">FAHIMI HD, DEREN JJ, GOTTLIEB LS, ZAMCHECK N. ISOLATED GRANULOMATOUS GASTRITIS: ITS RELATIONSHIP TO DISSEMINATED SARCOIDOSIS AND REGIONAL ENTERITIS. Gastroenterology 1963; 45:161.</a></li><li class="breakAll">Genta RM. Granulomatous gastritis. In: Gastritis, Graham DY, Genta RM, Dixon MF (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 1999.</li><li><a class="nounderline abstract_t">Sepulveda AR, Patil M. Practical approach to the pathologic diagnosis of gastritis. Arch Pathol Lab Med 2008; 132:1586.</a></li><li><a class="nounderline abstract_t">Liang Y, Cui S, Polydorides AD. Clinicopathological characteristics and aetiological factors of granulomatous gastritis. Histopathology 2021; 79:1040.</a></li><li><a class="nounderline abstract_t">Kamani L, Mumtaz K, Azad NS, Jafri W. Granulomatous gastritis: a diagnostic dilemma? Singapore Med J 2008; 49:e222.</a></li><li><a class="nounderline abstract_t">Renault M, Goodier A, Subramony C, et al. Age-related differences in granulomatous gastritis: a retrospective, clinicopathological analysis. J Clin Pathol 2010; 63:347.</a></li><li><a class="nounderline abstract_t">Oberhuber G, Püspök A, Oesterreicher C, et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 1997; 112:698.</a></li><li><a class="nounderline abstract_t">Wright CL, Riddell RH. Histology of the stomach and duodenum in Crohn's disease. Am J Surg Pathol 1998; 22:383.</a></li><li><a class="nounderline abstract_t">Laube R, Liu K, Schifter M, et al. Oral and upper gastrointestinal Crohn's disease. J Gastroenterol Hepatol 2018; 33:355.</a></li><li><a class="nounderline abstract_t">Xin W, Greenson JK. The clinical significance of focally enhanced gastritis. Am J Surg Pathol 2004; 28:1347.</a></li><li><a class="nounderline abstract_t">Owen DA. Gastritis and carditis. Mod Pathol 2003; 16:325.</a></li><li><a class="nounderline abstract_t">Afshar K, BoydKing A, Sharma OP, Shigemitsu H. Gastric sarcoidosis and review of the literature. J Natl Med Assoc 2010; 102:419.</a></li><li><a class="nounderline abstract_t">Vahid B, Spodik M, Braun KN, et al. Sarcoidosis of gastrointestinal tract: a rare disease. Dig Dis Sci 2007; 52:3316.</a></li><li><a class="nounderline abstract_t">Dulai PS, Rothstein RI. Disseminated sarcoidosis presenting as granulomatous gastritis: a clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis. J Clin Gastroenterol 2012; 46:367.</a></li><li><a class="nounderline abstract_t">Lauwers GY. Gastritis: beyond Helicobacter pylori. Int J Surg Pathol 2010; 18:28S.</a></li><li><a class="nounderline abstract_t">Ozturk Y, Buyukgebiz B, Ozer E, et al. Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy. J Pediatr Gastroenterol Nutr 2004; 39:286.</a></li><li><a class="nounderline abstract_t">Miyamoto M, Haruma K, Yoshihara M, et al. Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori. J Gastroenterol 2003; 38:371.</a></li><li><a class="nounderline abstract_t">Genta RM, Lash RH. Helicobacter pylori-negative gastritis: seek, yet ye shall not always find. Am J Surg Pathol 2010; 34:e25.</a></li><li><a class="nounderline abstract_t">Srivastava A, Lauwers GY. Pathology of non-infective gastritis. Histopathology 2007; 50:15.</a></li><li><a class="nounderline abstract_t">Kim YS, Lee HK, Kim JO, et al. A Case of H. pylori-associated Granulomatous Gastritis with Hypertrophic Gastropathy. Gut Liver 2009; 3:137.</a></li><li><a class="nounderline abstract_t">Yamane T, Uchiyama K, Ishii T, et al. Isolated granulomatous gastritis showing discoloration of lesions after Helicobacter pylori eradication. Dig Endosc 2010; 22:140.</a></li><li><a class="nounderline abstract_t">Lauwers GY, Fujita H, Nagata K, Shimizu M. Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons. J Gastroenterol 2010; 45:131.</a></li><li><a class="nounderline abstract_t">Sandmeier D, Bouzourene H. Does idiopathic granulomatous gastritis exist? Histopathology 2005; 46:352.</a></li><li><a class="nounderline abstract_t">Besses C, Sans-Sabrafen J, Badia X, et al. Ulceroinfiltrative syphilitic gastropathy: silver stain diagnosis from biopsy specimen. Am J Gastroenterol 1987; 82:773.</a></li><li><a class="nounderline abstract_t">Beckman JW, Schuman BM. Antral gastritis and ulceration in a patient with secondary syphilis. Gastrointest Endosc 1986; 32:355.</a></li><li><a class="nounderline abstract_t">Anai H, Okada Y, Okubo K, et al. Gastric syphilis simulating linitis plastica type of gastric cancer. Gastrointest Endosc 1990; 36:624.</a></li><li><a class="nounderline abstract_t">Niitsu H, Tanabe K, Tokumoto N, et al. Idiopathic granulomatous gastritis resembling a gastrointestinal stromal tumor. Case Rep Gastroenterol 2012; 6:502.</a></li><li><a class="nounderline abstract_t">Tsukada T, Nakano T, Miyata T, et al. Xanthogranulomatous gastritis mimicking malignant GIST on F-18 FDG PET. Ann Nucl Med 2012; 26:752.</a></li><li><a class="nounderline abstract_t">Kinoshita H, Yamaguchi S, Sakata Y, et al. A rare case of xanthogranuloma of the stomach masquerading as an advanced stage tumor. World J Surg Oncol 2011; 9:67.</a></li><li><a class="nounderline abstract_t">Tajima S, Waki M, Ohata A, et al. Xanthogranulomatous gastritis associated with actinomycosis: report of a case presenting as a large submucosal mass. Int J Clin Exp Pathol 2015; 8:1013.</a></li><li><a class="nounderline abstract_t">Munker M, Sharma OP. Fatal gastrointestinal haemorrhage in sarcoidosis: a previously unreported occurrence. Sarcoidosis 1987; 4:55.</a></li><li><a class="nounderline abstract_t">Akinyemi E, Rohewal U, Tangorra M, Abdullah M. Gastric sarcoidosis. J Natl Med Assoc 2006; 98:948.</a></li><li><a class="nounderline abstract_t">Gumaste VV, Janowitz HD, Waye JD. Granulomatous gastritis: a case report and review of the literature. Am J Gastroenterol 1989; 84:1315.</a></li></ol></div><div id="topicVersionRevision">Topic 9 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8604813" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A clinicopathologic study of 42 patients with granulomatous gastritis. Is there really an "idiopathic" granulomatous gastritis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8365714" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Granulomatous gastritis: a morphological and diagnostic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15223966" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Granulomatous gastritis: a clinicopathologic analysis of 18 biopsy cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14051727" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : ISOLATED GRANULOMATOUS GASTRITIS: ITS RELATIONSHIP TO DISSEMINATED SARCOIDOSIS AND REGIONAL ENTERITIS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14051727" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : ISOLATED GRANULOMATOUS GASTRITIS: ITS RELATIONSHIP TO DISSEMINATED SARCOIDOSIS AND REGIONAL ENTERITIS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18834216" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Practical approach to the pathologic diagnosis of gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34309057" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinicopathological characteristics and aetiological factors of granulomatous gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18830524" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Granulomatous gastritis: a diagnostic dilemma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20354205" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Age-related differences in granulomatous gastritis: a retrospective, clinicopathological analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9041230" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9537465" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Histology of the stomach and duodenum in Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28708248" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Oral and upper gastrointestinal Crohn's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15371951" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The clinical significance of focally enhanced gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12692198" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Gastritis and carditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20533777" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Gastric sarcoidosis and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17410465" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Sarcoidosis of gastrointestinal tract: a rare disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22334224" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Disseminated sarcoidosis presenting as granulomatous gastritis: a clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20484257" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Gastritis: beyond Helicobacter pylori.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15319630" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12743778" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20631607" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Helicobacter pylori-negative gastritis: seek, yet ye shall not always find.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17204018" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pathology of non-infective gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20431738" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A Case of H. pylori-associated Granulomatous Gastritis with Hypertrophic Gastropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20447210" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Isolated granulomatous gastritis showing discoloration of lesions after Helicobacter pylori eradication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19967418" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15720427" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Does idiopathic granulomatous gastritis exist?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2440299" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Ulceroinfiltrative syphilitic gastropathy: silver stain diagnosis from biopsy specimen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3770389" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Antral gastritis and ulceration in a patient with secondary syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2279662" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Gastric syphilis simulating linitis plastica type of gastric cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22855668" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Idiopathic granulomatous gastritis resembling a gastrointestinal stromal tumor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22744808" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Xanthogranulomatous gastritis mimicking malignant GIST on F-18 FDG PET.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21722385" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A rare case of xanthogranuloma of the stomach masquerading as an advanced stage tumor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25755811" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Xanthogranulomatous gastritis associated with actinomycosis: report of a case presenting as a large submucosal mass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3495838" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Fatal gastrointestinal haemorrhage in sarcoidosis: a previously unreported occurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16775918" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Gastric sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2679050" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Granulomatous gastritis: a case report and review of the literature.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
